{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:21:02Z","timestamp":1788981662524,"version":"build-2803163510"},"reference-count":129,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030 - 182651"],"award-info":[{"award-number":["310030 - 182651"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Telethon Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"MIUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.tips.2023.09.008","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T16:09:03Z","timestamp":1699286943000},"page":"963-977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cancer drug repurposing in autism spectrum disorder"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2844-8547","authenticated-orcid":false,"given":"Giorgia","family":"Pedini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4968-4920","authenticated-orcid":false,"given":"Chin-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1190-4481","authenticated-orcid":false,"given":"Tilmann","family":"Achsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4419-210X","authenticated-orcid":false,"given":"Claudia","family":"Bagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2023.09.008_bb0005","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism spectrum disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.tips.2023.09.008_bb0010","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2147\/NDT.S371013","article-title":"Pharmacological management of core symptoms and comorbidities of autism spectrum disorder in children and adolescents: a systematic review","volume":"18","author":"Maniram","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.tips.2023.09.008_bb0015","article-title":"Oncology outpatients with worse anxiety and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life","author":"Calvo-Schimmel","year":"2022","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.tips.2023.09.008_bb0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-genom-091416-035332","article-title":"Cognitive dysfunctions in intellectual disabilities: the contributions of the Ras-MAPK and PI3K-AKT-mTOR pathways","volume":"18","author":"Borrie","year":"2017","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.tips.2023.09.008_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.31887\/DCNS.2017.19.4\/sscherer","article-title":"Syndromic autism spectrum disorders: moving from a clinically defined to a molecularly defined approach","volume":"19","author":"Fernandez","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.tips.2023.09.008_bb0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(20)30217-9","article-title":"Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies","volume":"19","author":"Sandweiss","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2023.09.008_bb0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuroscience.2020.02.017","article-title":"Angelman syndrome: from mouse models to therapy","volume":"445","author":"Rotaru","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2023.09.008_bb0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-genom-083118-015354","article-title":"Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex","volume":"20","author":"Salussolia","year":"2019","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.tips.2023.09.008_bb0045","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1474-4422(22)00213-7","article-title":"Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy","volume":"21","author":"Curatolo","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2023.09.008_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","article-title":"Autism spectrum disorder","volume":"6","author":"Lord","year":"2020","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.tips.2023.09.008_bb0055","first-page":"248","article-title":"An update on psychopharmacological treatment of autism spectrum disorder","volume":"19","author":"Aishworiya","year":"2022","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.tips.2023.09.008_bb0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-444-63233-3.00021-X","article-title":"Genetics of autism spectrum disorder","volume":"147","author":"Ramaswami","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.tips.2023.09.008_bb0065","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.neuron.2019.02.041","article-title":"A synaptic perspective of fragile X syndrome and autism spectrum disorders","volume":"101","author":"Bagni","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2023.09.008_bb0070","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.pnpbp.2017.12.001","article-title":"Neurodevelopmental dynaptopathies: insights from behaviour in rodent models of synapse gene mutations","volume":"84","author":"Luo","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tips.2023.09.008_bb0075","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41588-022-01064-5","article-title":"A phenotypic spectrum of autism is attributable to the combined effects of rare variants, polygenic risk and sex","volume":"54","author":"Antaki","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2023.09.008_bb0080","first-page":"717","article-title":"Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis","volume":"128","author":"Wei","year":"2021","journal-title":"J. Neural Transm. Vienna Austria 1996"},{"key":"10.1016\/j.tips.2023.09.008_bb0085","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.3390\/ijerph17218089","article-title":"Impact of gene-environment interactions on cancer development","volume":"17","author":"Mbemi","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.tips.2023.09.008_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tig.2016.01.001","article-title":"Autism and cancer share risk genes, pathways, and drug targets","volume":"32","author":"Crawley","year":"2016","journal-title":"Trends Genet. TIG"},{"key":"10.1016\/j.tips.2023.09.008_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13229-019-0262-8","article-title":"Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer","volume":"10","author":"For\u00e9s-Martos","year":"2019","journal-title":"Mol. Autism"},{"key":"10.1016\/j.tips.2023.09.008_bb0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2022.12.001","article-title":"Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD)","volume":"108","author":"Hughes","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tips.2023.09.008_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2019.08.002","article-title":"Cancer and the immune system: the history and background of immunotherapy","volume":"35","author":"Abbott","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.tips.2023.09.008_bb0110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tips.2023.09.008_bb0115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cells10030659","article-title":"Signaling pathways in cancer: therapeutic targets, combinatorial treatments, and new developments","volume":"10","author":"Yip","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tips.2023.09.008_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tips.2023.09.008_bb0125","first-page":"1889","article-title":"mTOR signaling disruption and its association with the development of autism spectrum disorder","volume":"28","author":"Thomas","year":"2023","journal-title":"Mol. Basel Switz."},{"key":"10.1016\/j.tips.2023.09.008_bb0130","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: Are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tips.2023.09.008_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2023.09.008_bb0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","article-title":"mTOR as a central hub of nutrient signalling and cell growth","volume":"21","author":"Kim","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tips.2023.09.008_bb0145","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuron.2014.07.040","article-title":"Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits","volume":"83","author":"Tang","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2023.09.008_bb0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tips.2023.09.008_bb0155","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/ijms20051166","article-title":"GeneAnalytics pathways and profiling of shared autism and cancer genes","volume":"20","author":"Gabrielli","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2023.09.008_bb0160","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.tips.2023.09.008_bb0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.pbr.2018.09.008","article-title":"ERK\/MAPK signaling and autism spectrum disorders","volume":"241","author":"Vithayathil","year":"2018","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.tips.2023.09.008_bb0170","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/med.21787","article-title":"Direct targeting of \u03b2-catenin in the Wnt signaling pathway: Current progress and perspectives","volume":"41","author":"Wang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.tips.2023.09.008_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1739","article-title":"Prevalence and clinical\/molecular characteristics of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly","volume":"9","author":"Kaymakcalan","year":"2021","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.tips.2023.09.008_bb0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13041-020-00706-1","article-title":"Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras\/MAPK, Wnt\/\u03b2-catenin, and mTOR signaling during corticogenesis","volume":"13","author":"Casingal","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.tips.2023.09.008_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.764756","article-title":"Wnt\/\u03b2-catenin-dependent transcription in autism spectrum disorders","volume":"14","author":"Caracci","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tips.2023.09.008_bb0190","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.conb.2018.06.003","article-title":"Wnt proteins as modulators of synaptic plasticity","volume":"53","author":"McLeod","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.tips.2023.09.008_bb0195","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3390\/cancers11122002","article-title":"JAK-STAT Signaling: a double-edged sword of immune regulation and cancer progression","volume":"11","author":"Owen","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.tips.2023.09.008_bb0200","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1007\/s12035-017-0822-x","article-title":"Immune abnormalities in autism spectrum disorder-Could they hold promise for causative treatment?","volume":"55","author":"G\u0142adysz","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2023.09.008_bb0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cells9010217","article-title":"Role of JAK\/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial-mesenchymal transition","volume":"9","author":"Jin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tips.2023.09.008_bb0210","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1007\/s12035-022-02819-1","article-title":"Role of JAK-STAT and PPAR-gamma signalling modulators in the prevention of autism and neurological dysfunctions","volume":"59","author":"Khera","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2023.09.008_bb0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/dneu.22795","article-title":"Role of Ash1l in Tourette syndrome and other neurodevelopmental disorders","volume":"81","author":"Zhang","year":"2021","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.tips.2023.09.008_bb0220","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/s41380-022-01917-9","article-title":"Epigenomic signatures reveal mechanistic clues and predictive markers for autism spectrum disorder","volume":"28","author":"LaSalle","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tips.2023.09.008_bb0225","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1038\/s41467-021-23152-6","article-title":"Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity","volume":"12","author":"Rogawski","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2023.09.008_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.932914","article-title":"Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2023.09.008_bb0235","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tips.2023.09.008_bb0240","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ccell.2018.02.011","article-title":"GKAP acts as a genetic modulator of NMDAR signaling to govern invasive tumor growth","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2023.09.008_bb0245","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/s41416-022-01863-x","article-title":"The dark side of synaptic proteins in tumours","volume":"127","author":"Li","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tips.2023.09.008_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl7207","article-title":"Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion","volume":"378","author":"Zeng","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tips.2023.09.008_bb0255","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1038\/s41388-021-01824-3","article-title":"Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge","volume":"40","author":"Carotti","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.tips.2023.09.008_bb0260","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcmgh.2020.10.009","article-title":"The fragile X mental retardation protein regulates RIPK1 and colorectal cancer resistance to necroptosis","volume":"11","author":"Di Grazia","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2023.09.008_bb0265","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/1878-0261.13019","article-title":"MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB-EGF\/EGFR pathway","volume":"15","author":"Wang","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.tips.2023.09.008_bb0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/2159-8290.CD-15-0341","article-title":"MECP2 Is a frequently amplified oncogene with a novel epigenetic mechanism that mimics the role of activated RAS in malignancy","volume":"6","author":"Neupane","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tips.2023.09.008_bb0275","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1093\/hmg\/ddaa226","article-title":"Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex","volume":"29","author":"Arsenault","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2023.09.008_bb0280","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/cap.2016.0100","article-title":"Beneficial effects of everolimus on autism and attention-deficit\/hyperactivity disorder symptoms in a group of patients with tuberous sclerosis complex","volume":"27","author":"Kilincaslan","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.tips.2023.09.008_bb0285","doi-asserted-by":"crossref","first-page":"342","DOI":"10.18632\/oncotarget.28410","article-title":"Cancer prevention with rapamycin","volume":"14","author":"Blagosklonny","year":"2023","journal-title":"Oncotarget"},{"key":"10.1016\/j.tips.2023.09.008_bb0290","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10637-018-0645-2","article-title":"Phase I\/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer. Invest","volume":"37","author":"Weldon Gilcrease","year":"2019","journal-title":"New Drugs"},{"key":"10.1016\/j.tips.2023.09.008_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2021.100733","article-title":"A randomized double-blind controlled trial of everolimus in individuals with PTEN mutations: Study design and statistical considerations","volume":"21","author":"Hardan","year":"2021","journal-title":"Contemp. Clin. Trials Commun."},{"key":"10.1016\/j.tips.2023.09.008_bb0300","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/ijms18030659","article-title":"Dysfunctional mTORC1 signaling: a convergent mechanism between syndromic and nonsyndromic forms of autism spectrum disorder?","volume":"18","author":"Magdalon","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2023.09.008_bb0305","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bpsgos.2021.08.005","article-title":"Genetic and environmental contributions to autism spectrum disorder through mechanistic target of rapamycin","volume":"2","author":"Sato","year":"2022","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"10.1016\/j.tips.2023.09.008_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111574","article-title":"Disruption of mTORC1 rescues neuronal overgrowth and synapse function dysregulated by Pten loss","volume":"41","author":"Tariq","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2023.09.008_bb0315","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fnmol.2017.00452","article-title":"Negative effects of chronic rapamycin treatment on behavior in a mouse model of fragile X syndrome","volume":"10","author":"Sar\u00e9","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tips.2023.09.008_bb0320","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41419-022-05019-w","article-title":"FMRP modulates the Wnt signalling pathway in glioblastoma","volume":"13","author":"Pedini","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2023.09.008_bb0325","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajhg.2015.08.002","article-title":"Chromatin-remodeling-factor ARID1B represses Wnt\/\u03b2-catenin signaling","volume":"97","author":"Vasileiou","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tips.2023.09.008_bb0330","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7150\/ijbs.55636","article-title":"DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163\/TOP2A and activating Wnt\/\u03b2-catenin pathway","volume":"17","author":"Liu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tips.2023.09.008_bb0335","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220498","article-title":"Biallelic PAX5 mutations cause hypogammaglobulinemia, sensorimotor deficits, and autism spectrum disorder","volume":"219","author":"Kaiser","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2023.09.008_bb0340","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1038\/s41467-020-16799-0","article-title":"ADNP promotes neural differentiation by modulating Wnt\/\u03b2-catenin signaling","volume":"11","author":"Sun","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2023.09.008_bb0345","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005654","article-title":"FOXP1 potentiates Wnt\/\u03b2-catenin signaling in diffuse large B cell lymphoma","volume":"8","author":"Walker","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tips.2023.09.008_bb0350","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2021.09.018","article-title":"Novel ADNP syndrome mice reveal dramatic sex-specific peripheral gene expression with brain synaptic and Tau pathologies","volume":"92","author":"Karmon","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2023.09.008_bb0355","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/nn.4400","article-title":"Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling","volume":"19","author":"Durak","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2023.09.008_bb0360","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s43440-020-00162-7","article-title":"Tideglusib attenuates growth of neuroblastoma cancer stem\/progenitor cells in vitro and in vivo by specifically targeting GSK-3\u03b2","volume":"73","author":"Bahmad","year":"2021","journal-title":"Pharmacol. Rep. PR"},{"key":"10.1016\/j.tips.2023.09.008_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107939","article-title":"Novel treatments for autism spectrum disorder based on genomics and systems biology","volume":"230","author":"Baribeau","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2023.09.008_bb0370","doi-asserted-by":"crossref","first-page":"129","DOI":"10.9758\/cpn.2018.16.2.129","article-title":"The Wnt signaling pathway and related therapeutic drugs in autism spectrum disorder","volume":"16","author":"Bae","year":"2018","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.tips.2023.09.008_bb0375","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s43556-022-00099-8","article-title":"The role of Hedgehog and Notch signaling pathway in cancer","volume":"3","author":"Xia","year":"2022","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.tips.2023.09.008_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109644","article-title":"The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism","volume":"94","author":"Zhang","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tips.2023.09.008_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114131","article-title":"Roles of the Notch signaling pathway and microglia in autism","volume":"437","author":"Zhang","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tips.2023.09.008_bb0390","article-title":"DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis","volume":"2","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2015","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.tips.2023.09.008_bb0395","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-4614-0899-4_23","article-title":"Notch inhibition as a promising new approach to cancer therapy","volume":"727","author":"Purow","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tips.2023.09.008_bb0400","first-page":"553","article-title":"Discovery of rare mutations in autism: elucidating neurodevelopmental mechanisms","volume":"12","author":"Gamsiz","year":"2015","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.tips.2023.09.008_bb0405","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nm.3046","article-title":"Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy","volume":"19","author":"Lux\u00e1n","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2023.09.008_bb0410","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1042\/CS20180732","article-title":"MIB1 mutations reduce Notch signaling activation and contribute to congenital heart disease","volume":"1979","author":"Li","year":"2018","journal-title":"Clin. Sci. Lond. Engl."},{"key":"10.1016\/j.tips.2023.09.008_bb0415","article-title":"GSK-3\u03b2 inhibitor TWS119 alleviates hypoxic-ischemic brain damage via a crosstalk with Wnt and Notch signaling pathways in neonatal rats","volume":"2021","author":"Gao","year":"1768","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2023.09.008_bb0420","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1038\/s41598-021-88618-5","article-title":"Inhibition of Wnt signalling by Notch via two distinct mechanisms","volume":"11","author":"Acar","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2023.09.008_bb0425","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.3390\/ijms231810713","article-title":"Green tea catechins: Nature\u2019s way of preventing and treating cancer","volume":"23","author":"Farhan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2023.09.008_bb0430","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/brainsci8100187","article-title":"DYRK1A protein, a promising therapeutic target to improve cognitive deficits in Down syndrome","volume":"8","author":"Feki","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.tips.2023.09.008_bb0435","first-page":"2004","article-title":"Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)","volume":"24","author":"Cieuta-Walti","year":"2022","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"10.1016\/j.tips.2023.09.008_bb0440","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/aur.1966","article-title":"Cellular stress and apoptosis contribute to the pathogenesis of autism spectrum disorder","volume":"11","author":"Dong","year":"2018","journal-title":"Autism Res. Off. J. Int. Soc. Autism Res."},{"key":"10.1016\/j.tips.2023.09.008_bb0445","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresbull.2019.07.006","article-title":"The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T+ Itpr3tf\/J mouse model of autism","volume":"152","author":"Ahmad","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.tips.2023.09.008_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2019.12.003","article-title":"Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21\/IL-21R and JAK\/STAT pathway in the BTBR mouse model of autism","volume":"77","author":"Ahmad","year":"2020","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.tips.2023.09.008_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108758","article-title":"A selective peroxisome proliferator-activated receptor-\u03b3 agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress","volume":"311","author":"Mirza","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2023.09.008_bb0460","article-title":"Inhibition of elevated Ras-MAPK signaling normalizes enhanced motor learning and excessive clustered dendritic spine stabilization in the MECP2-duplication syndrome mouse model of autism","volume":"8","author":"Ash","year":"2021","journal-title":"eNeuro"},{"key":"10.1016\/j.tips.2023.09.008_bb0465","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13229-020-00406-6","article-title":"Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism","volume":"12","author":"Frazier","year":"2021","journal-title":"Mol. Autism"},{"key":"10.1016\/j.tips.2023.09.008_bb0470","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1083\/jcb.200404108","article-title":"The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells","volume":"167","author":"Schuetz","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2023.09.008_bb0475","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/cells11142211","article-title":"Potential cross talk between autism risk genes and neurovascular molecules: a pilot study on impact of blood brain barrier integrity","volume":"11","author":"Jagadapillai","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.tips.2023.09.008_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104565","article-title":"A clinically relevant selective ERK-pathway inhibitor reverses core deficits in a mouse model of autism","volume":"91","author":"Murari","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tips.2023.09.008_bb0485","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/brain\/awac398","article-title":"Mnk1\/2 kinases regulate memory and autism-related behaviours via Syngap1","volume":"146","author":"Chalkiadaki","year":"2023","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.tips.2023.09.008_bb0490","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijdevneu.2019.08.003","article-title":"SYNGAP1 mutations: Clinical, genetic, and pathophysiological features","volume":"78","author":"Agarwal","year":"2019","journal-title":"Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci."},{"key":"10.1016\/j.tips.2023.09.008_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.751742","article-title":"Topoisomerase-mediated DNA damage in neurological disorders","volume":"13","author":"Crewe","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tips.2023.09.008_bb0500","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcdb.2017.09.009","article-title":"Arc ubiquitination in synaptic plasticity","volume":"77","author":"Mabb","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.tips.2023.09.008_bb0505","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13229-018-0228-2","article-title":"Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome","volume":"9","author":"Lee","year":"2018","journal-title":"Mol. Autism"},{"key":"10.1016\/j.tips.2023.09.008_bb0510","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature12504","article-title":"Topoisomerases facilitate transcription of long genes linked to autism","volume":"501","author":"King","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tips.2023.09.008_bb0515","first-page":"3372","volume":"129","author":"Parveen","year":"2023","journal-title":"Recent histone deacetylase inhibitors in cancer therapy, Cancer"},{"key":"10.1016\/j.tips.2023.09.008_bb0520","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41593-018-0110-8","article-title":"Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition","volume":"21","author":"Qin","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2023.09.008_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136241","article-title":"Vorinostat, a histone deacetylase inhibitor, ameliorates the sociability and cognitive memory in an Ash1L-deletion-induced ASD\/ID mouse model","volume":"764","author":"Gao","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tips.2023.09.008_bb0530","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000517870","article-title":"Mitochondrial dysfunction: a common denominator in neurodevelopmental disorders?","volume":"43","author":"Ortiz-Gonz\u00e1lez","year":"2021","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.tips.2023.09.008_bb0535","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2023.09.008_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115219","article-title":"Recent advances of mitochondrial complex i inhibitors for cancer therapy: current status and future perspectives","volume":"251","author":"Zhou","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tips.2023.09.008_bb0545","article-title":"Mitochondrial dysfunction in autism spectrum disorder: unique abnormalities and targeted treatments","volume":"35","author":"Frye","year":"2020","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.tips.2023.09.008_bb0550","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.cell.2020.02.044","article-title":"Aralar sequesters GABA into hyperactive mitochondria, causing social behavior deficits","volume":"180","author":"Kanellopoulos","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tips.2023.09.008_bb0555","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev-med-081117-041238","article-title":"Metformin for treatment of fragile X syndrome and other neurological disorders","volume":"70","author":"Gantois","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tips.2023.09.008_bb0560","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.3390\/ijms23063033","article-title":"Immune dysregulation in autism spectrum disorder: What do we know about It?","volume":"23","author":"de L.A. Robinson-Agramonte","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2023.09.008_bb0565","first-page":"56","article-title":"Inflammation and neuro-immune dysregulations in autism spectrum disorders","volume":"11","author":"Siniscalco","year":"2018","journal-title":"Pharm. Basel Switz."},{"key":"10.1016\/j.tips.2023.09.008_bb0570","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41577-020-00487-7","article-title":"Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders","volume":"21","author":"Zengeler","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tips.2023.09.008_bb0575","doi-asserted-by":"crossref","first-page":"15271","DOI":"10.3390\/ijms232315271","article-title":"Blood-brain barrier disruption and its involvement in neurodevelopmental and neurodegenerative disorders","volume":"23","author":"Arag\u00f3n-Gonz\u00e1lez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2023.09.008_bb0580","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/pathogens11020193","article-title":"Pathogenic infections during pregnancy and the consequences for fetal brain development","volume":"11","author":"Jash","year":"2022","journal-title":"Pathog. Basel Switz."},{"key":"10.1016\/j.tips.2023.09.008_bb0585","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028456","article-title":"Interleukin (IL-6) immunotherapy","volume":"10","author":"Tanaka","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.tips.2023.09.008_bb0590","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mc.23234","article-title":"Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer","volume":"59","author":"Alraouji","year":"2020","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.tips.2023.09.008_bb0595","doi-asserted-by":"crossref","first-page":"8","DOI":"10.24869\/psyd.2023.8","article-title":"Monoclonal antibody therapy in autoantibody-associated psychotic disorders and schizophrenia: narrative review of past and current clinical trials","volume":"35","author":"Hansen","year":"2023","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.tips.2023.09.008_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.595722","article-title":"Dynamic immune\/inflammation precision medicine: the good and the bad inflammation in infection and cancer","volume":"12","author":"Rossi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2023.09.008_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2020.100836","article-title":"Immune modulatory treatments for autism spectrum disorder","volume":"35","author":"Thom","year":"2020","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.tips.2023.09.008_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.995439","article-title":"Drug repurposing candidates to treat core symptoms in autism spectrum disorder","volume":"13","author":"Koch","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2023.09.008_bb0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004580","article-title":"Meta-analysis of SHANK mutations in autism spectrum disorders: A gradient of severity in cognitive impairments","volume":"10","author":"Leblond","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tips.2023.09.008_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102019","article-title":"Review of precision cancer medicine: evolution of the treatment paradigm","volume":"86","author":"Tsimberidou","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.tips.2023.09.008_bb0625","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/2159-8290.CD-21-0212","article-title":"Independent drug action in combination therapy: implications for precision oncology","volume":"12","author":"Plana","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tips.2023.09.008_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110517","article-title":"Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases","volume":"38","author":"Marcogliese","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2023.09.008_bb0635","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.3390\/ijms20174071","article-title":"Autism spectrum disorder-related syndromes: modeling with Drosophila and rodents","volume":"20","author":"Ueoka","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2023.09.008_bb0640","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature10726","article-title":"Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons","volume":"481","author":"Huang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tips.2023.09.008_bb9000","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1523\/JNEUROSCI.0420-19.2020","article-title":"Twenty years of SynGAP research: from synapses to cognition","volume":"40","author":"Gamache","year":"2020","journal-title":"J. Neurosci."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614723002109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614723002109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:52:06Z","timestamp":1777495926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614723002109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":129,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0165614723002109"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2023.09.008","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer drug repurposing in autism spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2023.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}